Based on the VESPER trial data, do you recommend the full 6 cycles or 3-4 cycles of ddMVAC for neoadjuvant muscle invasive bladder cancer treatment?  

GETUG-AFU V05 VESPER Trial

Did the ASCO 2023 overall survival data change your practice?

 



Answer from: Medical Oncologist at Academic Institution